HIGHLIGHTS
- who: Fahimeh Varzideh from the University of Brescia, Italy have published the research work: Aprocitentan: New insights, in the Journal: (JOURNAL) of 18/06/2018
- how: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- future: For instance future studies with a long-term follow-up evaluating the effects of aprocitentan on cardiovascular outcomes and target-organ damage are warranted.
SUMMARY
ACT-132577, aprocitentan, blood pressure, clinical trial, endothelin, hypertension, PRECISION . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.